ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Avalo Therapeutics Inc

Avalo Therapeutics Inc (AVTX)

19.645
14.90
( 313.58% )
Updated: 09:35:12

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
19.645
Bid
19.30
Ask
19.90
Volume
3,455,239
17.00 Day's Range 20.14
3.9501 52 Week Range 1,130.40
Market Cap
Previous Close
4.75
Open
18.68
Last Trade
2
@
19.6331
Last Trade Time
09:35:12
Financial Volume
$ 63,806,078
VWAP
18.4665
Average Volume (3m)
89,473
Shares Outstanding
801,611
Dividend Yield
-
PE Ratio
-0.06
Earnings Per Share (EPS)
-51.97
Revenue
18.05M
Net Profit
-41.66M

About Avalo Therapeutics Inc

Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing... Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing in development with ongoing clinical programs: AVTX-002, AVTX-007, and AVTX-006. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Avalo Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AVTX. The last closing price for Avalo Therapeutics was $4.75. Over the last year, Avalo Therapeutics shares have traded in a share price range of $ 3.9501 to $ 1,130.40.

Avalo Therapeutics currently has 801,611 shares outstanding. The market capitalization of Avalo Therapeutics is $2.35 million. Avalo Therapeutics has a price to earnings ratio (PE ratio) of -0.06.

AVTX Latest News

Avalo Acquires Anti-IL-1Ξ² mAb and Announces Private Placement Financing of up to $185 Million

Avalo acquires Phase 2-ready anti-IL-1Ξ² mAb, AVTX-009, through acquisition of AlmataBio, Inc. Topline results from planned Phase 2 trial in hidradenitis suppurativa expected in 2026Executed...

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13G/A   Under the Securities Exchange Act of 1934 (Amendment...

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

  SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     SCHEDULE 13G/A   Under the Securities Exchange Act of 1934 (Amendment No. 3...

Form 8-K - Current report

0001534120false00015341202024-01-302024-01-30UNITED STATESSECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549  FORM 8-K  CURRENT REPORT Pursuant to Section 13 or 15(d) of the...

Form 8-K - Current report

0001534120false12/3100015341202023-12-282023-12-28UNITED STATESSECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549  FORM 8-K  CURRENT REPORT Pursuant to Section 13 or 15(d) of...

Avalo Therapeutics Announces 1-for-240 Reverse Stock Split

WAYNE, Pa. and ROCKVILLE, Md., Dec. 27, 2023 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) today announced a 1-for-240 reverse stock split of the Company’s common stock, par value...

Form 4 - Statement of changes in beneficial ownership of securities

SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...

Form 4 - Statement of changes in beneficial ownership of securities

SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
115.175339.4854586134.4720.384.436097544.75072503CS
415.135335.5875831494.5120.384.28351793654.81618866CS
1211.865152.5064267357.7820.383.9501894734.99207325CS
26-15.875-44.693130630635.5245.0963.95012214192826.26513453CS
52-397.955-95.2957375479417.61130.43.95012325746933.55825535CS
156-669.155-97.1479384437688.81711.23.9501916777339.4516355CS
260-669.155-97.1479384437688.81711.23.9501916777339.4516355CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AVTXAvalo Therapeutics Inc
$ 20.02
(321.47%)
3.38M
XLOXilio Therapeutics Inc
$ 1.71
(167.61%)
11.88M
BDRXBiodexa Pharmaceuticals PLC
$ 1.4789
(72.17%)
14.45M
AKANAkanda Corporation
$ 0.2522
(52.94%)
30.49M
PIKKidpik Corporation
$ 4.99
(52.60%)
5.49M
GMDAGamida Cell Ltd
$ 0.0436
(-26.35%)
15.15M
UGROUrban Gro Inc
$ 1.38
(-23.97%)
87.91k
NCNANuCana PLC
$ 0.24565
(-19.89%)
343.93k
MLKNMillerKnoll Inc
$ 25.105
(-17.77%)
323.3k
TNXPTonix Pharmaceuticals Holding Corporation
$ 0.2702
(-17.34%)
959.57k
AKANAkanda Corporation
$ 0.2522
(52.94%)
30.49M
KTRAKintara Therapeutics Inc
$ 0.1023
(14.30%)
20.22M
AKBAAkebia Therapeutics Inc
$ 2.20
(-1.79%)
19.14M
CISSC3is Inc
$ 0.0348
(-8.90%)
17.11M
GMDAGamida Cell Ltd
$ 0.0436
(-26.35%)
15.15M

AVTX Discussion

View Posts
Moonboy1 Moonboy1 53 minutes ago
Another holo? Congrats for the holders here. Will be interesting watching people chase this and lose their a--
πŸ‘οΈ0
Roadtojourney Roadtojourney 2 hours ago
As per per, They are getting $115 million upfront payment that will go beyond 2027. And someone mentioned the float is 800k.
πŸ‘οΈ0
PennyPusher786 PennyPusher786 13 hours ago
Although if you multiply by the peak price at the beginning of winter of about .25 cents... that's like $60.... and .12-.13 where it was mostly at is more like a $30 mark and a break even for many... so... I wouldn't get excited yet
πŸ‘οΈ0
PennyPusher786 PennyPusher786 13 hours ago
Finally a chance to get out with sizeable returns lol... and hopefully it doesn't tank in the morning and instead runs to 30+ ahaha

πŸ‘οΈ0
apr1 apr1 16 hours ago
Holy smokes! I bought 200 shares of this at 4.91 last Friday and just sold at 22.50 for a sweet 460% profit. That doesn’t happen often. 973$ to 4,500$ in 2 hours.
👍️ 1
TIMGZ TIMGZ 16 hours ago
ELECTION IS COMING
πŸ‘οΈ0
Invest-in-America Invest-in-America 16 hours ago
AVTX: So there goes ALL of our trading theories, down the toilet!!! (Now it's grab them any time, & flip them any time!!!)
πŸ‘οΈ0
TIMGZ TIMGZ 16 hours ago
400 PERCCEEEENT
πŸ‘οΈ0
Invest-in-America Invest-in-America 16 hours ago
AVTX: A 6-bagger for sure, even before the looming Open!!!
πŸ‘οΈ0
Awl416 Awl416 16 hours ago
Wild
πŸ‘οΈ0
surf1944 surf1944 17 hours ago
https://stockcharts.com/h-sc/ui?s=avtx&p=D&yr=0&mn=6&dy=0&id=p38090673899

https://www.barchart.com/stocks/quotes/avtx/technical-chart?plot=CANDLE&volume=total&data=DO&density=M&pricesOn=1&asPctChange=0&logscale=1&indicators=BBANDS(20,2);SMA(13);PTP(50);ADX(14);SMA(50);SMACD(12,26,9);RSI(14,100);ACCUM;STOSL(14,3)&sym=CNNA&grid=1&height=500&studyheight=100

https://www.barchart.com/stocks/quotes/avtx/opinion

https://finance.yahoo.com/quote/avtx/

Short sell!
πŸ‘οΈ0
TheFinalCD TheFinalCD 18 hours ago
NO WAY

LL
πŸ‘οΈ0
Awl416 Awl416 18 hours ago
Avalo Acquires Anti-IL-1ß mAb and Announces Private Placement Financing of up to $185 Million
πŸ‘οΈ0
TheFinalCD TheFinalCD 18 hours ago
$avtx 11.11 NEWS https://ir.avalotx.com/press-releases/detail/183/avalo-acquires-anti-il-1-mab-and-announces-private

https://finviz.com/quote.ashx?t=AVTX&p=d

Cash Position

The company has -2.7 months of cash left based on quarterly cash burn of -$9.3M and estimated current cash of $-8.4M.
https://dilutiontracker.com/app/search/AVTX
πŸ‘οΈ0
Monksdream Monksdream 2 weeks ago
AVTX 10Qndueb3/18
πŸ‘οΈ0
Monksdream Monksdream 3 weeks ago
AVTX 10Q March 11
πŸ‘οΈ0
Monksdream Monksdream 4 weeks ago
AVTX 10Q March 4
πŸ‘οΈ0
oldstocks oldstocks 1 month ago
RespireRx Pharmaceuticals RSPI $ KRM–II–81 has shown promising results for Epilepsy.
Has fully suppressed the epileptiform activity in the excised brain tissue from a 19-year-old patient with pharmaco-resistant epilepsy.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10784158/
πŸ‘οΈ0
oldstocks oldstocks 1 month ago
CERECOR in September 2016 acquired right to Anti Epilepsy Drug LY3130481 from Eli Lilly Cerecor branded drug CERC-611
Cerecor and Aevi Genomic Medicine Merged Feb 2020
Cerecor rebranded into Avalo Therapeutics ticker AVTX
Avalo Therapeutics (formerly Cerecor) is developing AVTX 611 (formerly CERC 611)
November 2022 Avalo Therapeutics enters into an agreement with ES Therapeutics to sell its net economic rights to future payments of previously out-licensed assets including CERC 611
AVTX 611 got rebranded to ES 481 is being developed by ES Therapeutics for the treatment of Epilepsy.
Clinical development is underway in Australia and Canada.
Study Design
Total Participants: 24
Study Start date:
November 21, 2021
Estimated Completion Date:
December 31, 2023

This webpage mentions:
The value of human epileptic tissue in the characterization and development of novel antiepileptic drugs: The example of CERC-611 and KRM-II-81
https://www.sciencedirect.com/science/article/abs/pii/S000689931930410X




The value of human epileptic tissue in the characterization and development of novel antiepileptic drugs: The example of CERC-611 and KRM-II-81
Abstract
The need for improved antiepileptics is clearly mandated despite the existence of multiple existing medicines from different chemical and mechanistic classes. Standard of care agents do not fully control epilepsies and have a variety of side-effect and safety issues. Patients typically take multiple antiepileptic drugs and yet many continue to have seizures. Antiepileptic-unresponsive seizures are life-disrupting and life-threatening. One approach to seizure control is surgical resection of affected brain tissue and associated neural circuits. Although non-human brain studies can provide insight into novel antiepileptic mechanisms, human epileptic brain is the bottom-line biological substrate. Human epileptic brain can provide definitive information on the presence or absence of the putative protein targets of interest in the patient population, the potential changes in these proteins in the epileptic state, and the engagement of novel molecules and their functional impact in target tissue. In this review, we discuss data on two novel potential antiepileptic drugs. CERC-611 (LY3130481) is an AMPA receptor antagonist that selectively blocks AMPA receptors associated with the auxiliary protein TARP ?-8 and is in clinical development. KRM-II-81 is a positive allosteric modulator of GABAA receptors selectively associated with protein subunits a2 and a 3. Preclinical data on these compounds argue that patient-based biological data increase the probability that a newly discovered molecule will translate its antiepileptic potential to patients.
πŸ‘οΈ0
Meangene818 Meangene818 2 months ago
May grab some today. Could be making the turn now
πŸ‘οΈ0
PennyPusher786 PennyPusher786 2 months ago
It's possible
πŸ‘οΈ0
PennyPusher786 PennyPusher786 2 months ago
Dammmmn down from $1000 in July to $5.... suddenly I have more faith in AMC lol
πŸ‘οΈ0
Meangene818 Meangene818 2 months ago
Hmmmmm!!
πŸ‘οΈ0
DeafTrader2 DeafTrader2 3 months ago
www.zacks.com STRONG BUY #1 wowza
πŸ‘οΈ0
Stockexpertpro Stockexpertpro 3 months ago
45 Million Dollar Milestone payment and over 10 Million in cash no debt This could push cash over 50$ per share waiting for data tiny float now after massive 240 for 1 RS
πŸ‘οΈ0
m_m007 m_m007 3 months ago
Back below a dollar in 2024
πŸ‘οΈ0
colorfullife88200 colorfullife88200 3 months ago
For shareholders best interest ? tomorrow is the day ! 1 for 240 RS !!! Most wipe out , You make money by trading , they make $$ by RS ....right ?
πŸ‘οΈ0
ErnieBilco ErnieBilco 3 months ago
Dirtbags changed ratio to 240 to 1 and moved the date to the 29th - just doesn't get much more pinkish than this group of clowns.
πŸ‘οΈ0
ErnieBilco ErnieBilco 3 months ago
Ouchhhhheeee 250 to 1 RS tomorrow - the illusion of being a real company continues with a stolen pps increase by theft.
πŸ‘οΈ0
peanutz peanutz 3 months ago
23 million on the ask ? Really
πŸ‘οΈ0
peanutz peanutz 3 months ago
Pre market boom is happening !
πŸ‘οΈ0
peanutz peanutz 3 months ago
That's why I'm in this . The float is tiny and you are right, it will be untradable . Damn shame for sure .
πŸ‘οΈ0
DERBYBLOOD DERBYBLOOD 3 months ago
Dude....they ALREADY DID the 1 for 12 RS back in 2022.... taking it from 192 mill. to current 16 mill.

Remember.... I CALLED the transfer agent to CHECK on that?

Whatever they do NOW will take it from 16 mill. TO something completely UN-tradable...and these exec's DON'T GET THAT...
πŸ‘οΈ0
DERBYBLOOD DERBYBLOOD 3 months ago
Man... I found the CEO & CFO on Linkedin and wrote to them. THIS is what I sent -

Your Reverse Split

Avalo JUST DID a RS in 2022 Your free trading float is ONLY 16 million.
In market terms, that it TINY...almost MICRO-float....and you're proxy is for ANOTHER ONE ???

A. You'll split so far that AVTX will be UN-TRADEABLE, no one will touch it, the stock will not "trend" on ANY chart. It will bouce up and down in WILD swings (chop)...
B. All you need to do right now is cancel the RS to get AVTX "FLYING" with a 16 mill. float.
C. You all just need to COMMUNICATE more with the market via PR's

Biotech and pharma Co.s are notorious for remaining silent about things and developments most of the time and it's a big mistake.

I've been doing this for over 30 years. I know what I'm talking about.

PR the cancellation of the RS, Your common stock holders and traders RAISE the price of AVTX...not the Preferred class holders...
....and Avalo needs to be more visible in the press. Sure a RS will raise the share price....but it will be cutting off your nose to spite your face.


....and they did it ANYWAY...morons
πŸ‘οΈ0
peanutz peanutz 3 months ago
I saw 1 for 5, 1 for 250 or somewhere in between is why it didn't make sense. Needs news prior to move it .
πŸ‘οΈ0
PennyPusher786 PennyPusher786 3 months ago
I think they will opt for 1 for 50 and that brings the operating shares from 192,000,000 to about 3,800,000 and the share price to about $2

That seems to make the most sense.... then they better do some insider purchases or drop some damn news to make it rippppp to $10+
πŸ‘οΈ0
peanutz peanutz 3 months ago
Well isn't this a bitch ! R/S . Low float anyway so wonder what price they are shooting for ?
πŸ‘οΈ0
peanutz peanutz 3 months ago
.0415 getting eaten up ! Bounce !
πŸ‘οΈ0
DERBYBLOOD DERBYBLOOD 3 months ago
ALRIGHT 503600 shares @ .06 at 12:30pm

THAT's what I'm talkin about !!!
πŸ‘οΈ0
DERBYBLOOD DERBYBLOOD 3 months ago
See....we FINALLY get the newbie idiots out of the way...full of fear....no "experience"...and unloading theirs for "nothing"....and NOW she TURNS at 11:45am........ I hope she leaves you jokers in the dust that have been trying to sell HUGE blocks of shares on the ASK and blocking the climb...
πŸ‘οΈ0
PennyPusher786 PennyPusher786 3 months ago
Still a 100% move up from the bottom .0333
πŸ‘οΈ0
PennyPusher786 PennyPusher786 3 months ago
If they don't get the vote for their reverse split, this is likely to go to the OTC for a short while no? Who knows a buyout can happen at any time if their intellectual property is worth anything
πŸ‘οΈ0
DERBYBLOOD DERBYBLOOD 3 months ago
Who's the "newbie" idiot sitting on the ASK with 124K BLOCK of shares putting up a "wall" at .07 ???

If you're wondering where the MOMO has gone and "why" ? yeah.... it's YOU....It's not rocket science...

YOU are the one holding the morning climb BACK.

Problem with these low prices stocks is it gives too many poor guys with no money the opp to get in...who don't know HOW to trade, HOW to enter and exit...

It's a LOW FLOAT...you HAVE TO give the trade time to BREATH...you can't keep flipping in and out with a low floater...otherwise you're just "running up a sand dune"

This should have touched 0.10 by now instead of struggling to get BACK to .07!

Break up your order newbie....NO trader sells on the ASK like that...they "fade" the selling... LEARN HOW TO TRADE geesh
πŸ‘οΈ0
INFINITI INFINITI 3 months ago
Looking forward to that
πŸ‘οΈ0
Meangene818 Meangene818 3 months ago
.14 by Tuesday IMO
πŸ‘οΈ0
INFINITI INFINITI 3 months ago
Thin to .08
πŸ‘οΈ0
PennyPusher786 PennyPusher786 3 months ago
Agreed....
πŸ‘οΈ0
PennyPusher786 PennyPusher786 3 months ago
My response to you wasn't intended as disrespect or belittlement
πŸ‘οΈ0
DERBYBLOOD DERBYBLOOD 3 months ago
glad you got "in and OUT" there Ace lolol
πŸ‘οΈ0
DERBYBLOOD DERBYBLOOD 3 months ago
"WAKE UP DUDE" ??? I trade with ALL the key data "sonny" I've been trading these markets SINCE 1995

I was trading on DATEK platform BEFORE Ameritrade merged / BOUGHT DATEK in 2002...

I just called the Transfer Agent to confirm THE FLOAT ( which is MISSING out of YOUR "key data" my little embryo )

It's 16 million last RS was in 2022 1 for 12.... So we ARE at 16 mill....

People are just trading the piss out of it....scared to hold.... 16 mill TINY float....going to make her "whippy as hell" !!!

Gotta have HUGE balls ( like mine ) ability to read your charts like the morning paper and 28 years of watching real time charts until your EYES BLEED to trade low floaters...
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock